Drugs / stable isotope-labelled leucine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT02263235 Background | Oct 2013 → May 2018 | Alzheimer disease, Parkinson disease, brain injury, hydrocephalus | University Hospital, Montpellier | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | stable isotope-labelled leucine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02263235 ↗ |